Japanese Billionaire Masayoshi Son’s Latest Portfolio: Top 5 Stock Picks

Page 5 of 5

1. EQRx, Inc. (NASDAQ:EQRX)

SB Management’s Stake Value: $294 million

Percentage of SB Management’s Portfolio: 29.11%

Number of Hedge Fund Holders: 31

Japanese billionaire Masayoshi Son’s SB Management bought a huge stake in EQRx, Inc. (NASDAQ:EQRX) upon its NASDAQ debut in the December quarter. The firm purchased 43.17 million shares of the company valued at around $294 million as of December 31, accounting for a sizable 29% of the value of its 13F portfolio.

The company aims to build a portfolio of innovative, low-cost treatments and develop unique long-term collaborations with other key industry players. There are two pre-registrational oncology assets (sugemalimab and aumolertinib) in EQRx’s pipeline that have demonstrated positive Phase 3 data for the treatment of advanced non-small-cell lung cancer.

You can also take a look at 10 Dividend Stocks Warren Buffett is Backing in 2022 and 10 Dividend Stocks to Buy According to Billionaire Jeffrey Talpins.

Page 5 of 5